HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bacteriological study of pyoderma with special reference to antibiotic susceptibility to newer antibiotics.

Abstract
Five hundred and forty-two cases of pyoderma were investigated to study bacterial aetiology and their antibiotic susceptibility patterns. Of these 65.87% cases were of primary pyoderma and the rest were of secondary pyoderma. Maximum cases were of impetigo (38.78%) followed by folliculitis (12.92%), furunculosis (2.95%), ecthyma (3.5%), carbuncle (1.5%) and sycosis barbae (0.4%). Secondary pyoderma constituted infected trophic ulcer (18.82%), infected pemphigus (7.2%), infected contact dermatitis (6.27%), and infected scabies (1.8%). Single organism was isolated from 46.9% cases and more than one type of organisms in 65.46% of cases. No organism was isolated in 5% of cases. Staphylococcus (67.34%) was the predominant species isolated followed by beta-haemolytic streptococcus (21.77%). Maximum strains of Staph. aureus were susceptible to amikacin (75%), co-trimoxazole (72%), cefotaxime (65%), chloramphenicol (62%), ciprofloxacin (61%) and clindamycin (61%). There was low susceptibility to cephaloridin (11%), gentamicin (12%) and penicillin (21%). Streptococcus betahaemolyticus was highly sensitive to most of the antibiotics and less sensitive to cefotaxime (7%), co-trimoxazole (11%) and penicillin (27%). Most of the strains were found to be resistant to one or more antibiotics.
AuthorsD P Ghadage, Y A Sali
JournalIndian journal of dermatology, venereology and leprology (Indian J Dermatol Venereol Leprol) 1999 Jul-Aug Vol. 65 Issue 4 Pg. 177-81 ISSN: 0378-6323 [Print] United States
PMID20921649 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: